This EU project seeks to provide Europe with a major time advantage over their main international competitors by developing a bionanotechnological device that can be used as a nanoactuator/biosensor, which also provides a novel interface between the Biological and Silicon Worlds.
The BioNanoMedTech competence network for biomolecular, regenerative methods and nanobiotechnology in medical engineering internationally promotes the industrial application of nanobiotechnology with the foci regenerative medicine and in-vitro diagnostics. BioNanoMedTech covers the entire value chain of regenerative medical engineering from basic research to clinical practice to the medical product.
BioNanoNet is a bionanotechnology network in Austria that carries out innovative interdisciplinary research in the field of drug development. Within this network new agents, action and application strategies are being developed by using techniques of nanotechnology. Research efforts are aimed at finding new agents and new treatment strategies for chronic degenerative and infectious diseases.
The BIOTEX project aims at developing dedicated biochemical-sensing techniques compatible with integration into textile. The consortium includes two research institutes in the field of micro and nanotechnology.
The mission of the group is to provide a rewarding and nourishing atmosphere of hands-on cutting edge research for students to develop and grow professionally and technically and use as an opportunity to springboard to a professional career that will benefit them and society.
The department has a strong record of research, with faculty involved in both experimental and theoretical areas. Some areas of current interest are: novel electronic materials; carbon nanotubes and nanotube arrays; theory of marginal Fermi liquids; optical and transport properties of low- dimensional condensed matter systems; novel superconductors.
Research in Optical Characterization and Nanophotonics (OCN) laboratory focuses on developing and applying advanced optical characterization techniques to the study of solid-state and biological phenomena at the nanoscale.
Shiladitya Sengupta's laboratory is focused on developing engineering solutions for complex disease. The team's research lies at the interfaces of fundamental biology, medical applications and nanoscale engineering, where basic understanding of biology inspires the development of novel technology or medical applications.
Highly interdisciplinary and translational, the group's research is focused on multifunctional, nanoparticle-based drug delivery systems. They seek to improve nanoparticle synthesis and formulation and its therapeutic efficacy. Additionally, they develop robust engineering processes to accelerate translation of nanoparticle-based drugs into the drug development pipeline. At the same time, they emphasize a fundamental understanding of the interface between nanomaterials and biological systems.
With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK.
The lab of Prof. Kenneth Breuer is active in research covering a wide variety of topics, including: Micron and nanometer scale fluid mechanics; Animal motion, in particular, bat flight and bacterial motility; Turbulent shear flows and shear flow control; Diagnostic methods for fluid mechanics.
The Institute for Molecular and Nanoscale Innovation (IMNI) was founded at Brown University in 2007 as an umbrella organization to support centers and collaborative research teams in targeted areas of the molecular and nanosciences. IMNI is a polydisciplinary venture with 55 faculty participants representing nine departments across campus. IMNI serves as a focal point for interaction with industry, government, and our affiliated hospitals.
The R. Hurt laboratory at Brown focuses on the creation of 3D nanomaterial architectures and new nano-enabled technologies. They also study the potential adverse effects of emerging 2D nanomaterials on human health and the environment and work to identify safe design rules rooted in fundamental materials chemistry and physics that will enable their successful development and commercialization.
Prof. Webster directs the Nanomedicine Laboratory which designs, synthesizes, and evaluates nanomaterials for various implant applications. Nanomaterials are central to the field of nanotechnology and are materials with one dimension less than 100 nm. Tissues investigated include bone, bladder, vascular, cartilage, dental, and the nervous system.
Nanofabrication manufacturing technology relates to the creation of microscopic structures. This technology is the basis of such diverse areas as computer chip manufacturing, flat panel displays and large scale solar power arrays used in space exploration, biological implants, medicine and pharmaceuticals. Rapid growth in these industries has created a strong demand for technicians with training in the intricacies of nanofabrication techniques and clean room procedures. Students enrolling in either program will spend three semesters on BCCC campus and the final capstone semester on Penn State campus.